In our study, inflammatory cytokines TNF-a, C-Reactive Protein (CRP), and Interleukin 6 (IL-6) significantly differed between patients with moderate and severe COVID-19, indicating their potential as parameters for severity. The gene discussed is TNF; the disease is COVID-19.